Rock Springs Capital Management as of Sept. 30, 2014
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 83 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 6.0 | $39M | 363k | 106.45 | |
| Medtronic | 5.1 | $33M | 528k | 61.95 | |
| Abbvie (ABBV) | 4.7 | $30M | 525k | 57.76 | |
| Merck & Co (MRK) | 4.4 | $28M | 475k | 59.28 | |
| McKesson Corporation (MCK) | 3.9 | $25M | 129k | 194.67 | |
| Hca Holdings (HCA) | 3.5 | $23M | 320k | 70.52 | |
| Actavis | 3.3 | $21M | 88k | 241.28 | |
| Amgen (AMGN) | 3.1 | $20M | 145k | 140.46 | |
| Biogen Idec (BIIB) | 3.1 | $20M | 61k | 330.81 | |
| Celgene Corporation | 2.4 | $16M | 166k | 94.78 | |
| Alexion Pharmaceuticals | 2.3 | $15M | 90k | 165.82 | |
| Thoratec Corporation | 2.1 | $14M | 521k | 26.73 | |
| Thermo Fisher Scientific (TMO) | 2.0 | $13M | 109k | 121.70 | |
| AVANIR Pharmaceuticals | 2.0 | $13M | 1.1M | 11.92 | |
| Cooper Companies | 1.7 | $11M | 69k | 155.75 | |
| Flamel Technologies | 1.6 | $11M | 735k | 14.31 | |
| CVS Caremark Corporation (CVS) | 1.6 | $10M | 130k | 79.59 | |
| Humana (HUM) | 1.6 | $10M | 80k | 130.29 | |
| Pharmacyclics | 1.6 | $10M | 85k | 117.43 | |
| Pacira Pharmaceuticals (PCRX) | 1.5 | $9.9M | 102k | 96.92 | |
| Envision Healthcare Hlds | 1.5 | $9.9M | 286k | 34.68 | |
| Acadia Healthcare (ACHC) | 1.5 | $9.8M | 203k | 48.50 | |
| athenahealth | 1.4 | $8.9M | 68k | 131.69 | |
| RTI Biologics | 1.4 | $8.9M | 1.9M | 4.78 | |
| Hill-Rom Holdings | 1.4 | $8.8M | 213k | 41.43 | |
| Team Health Holdings | 1.4 | $8.7M | 151k | 57.99 | |
| Aetna | 1.3 | $8.6M | 106k | 81.00 | |
| Intuitive Surgical (ISRG) | 1.3 | $8.5M | 19k | 461.84 | |
| Valeant Pharmaceuticals Int | 1.1 | $7.3M | 56k | 131.20 | |
| Cardinal Health (CAH) | 1.1 | $6.9M | 92k | 74.92 | |
| CIGNA Corporation | 1.1 | $6.8M | 75k | 90.69 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.0 | $6.5M | 58k | 112.31 | |
| Danaher Corporation (DHR) | 1.0 | $6.5M | 85k | 75.98 | |
| HeartWare International | 1.0 | $6.4M | 82k | 77.63 | |
| Illumina (ILMN) | 0.9 | $6.1M | 37k | 163.92 | |
| MWI Veterinary Supply | 0.9 | $5.8M | 39k | 148.41 | |
| Stericycle (SRCL) | 0.8 | $5.5M | 47k | 116.55 | |
| Orexigen Therapeutics | 0.8 | $5.3M | 1.3M | 4.26 | |
| Incyte Corporation (INCY) | 0.8 | $5.1M | 103k | 49.05 | |
| Catalent (CTLT) | 0.8 | $5.0M | 201k | 25.03 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $4.9M | 315k | 15.67 | |
| Puma Biotechnology (PBYI) | 0.8 | $4.9M | 21k | 238.59 | |
| Tesaro | 0.7 | $4.8M | 178k | 26.92 | |
| WellCare Health Plans | 0.7 | $4.6M | 76k | 60.34 | |
| Prothena (PRTA) | 0.7 | $4.5M | 203k | 22.16 | |
| Rite Aid Corporation | 0.7 | $4.4M | 914k | 4.84 | |
| Perrigo Company (PRGO) | 0.7 | $4.3M | 29k | 150.18 | |
| Agilent Technologies Inc C ommon (A) | 0.6 | $4.1M | 73k | 56.98 | |
| Allergan | 0.6 | $4.1M | 23k | 178.20 | |
| Novadaq Technologies | 0.6 | $3.9M | 310k | 12.69 | |
| CHINA CORD Blood Corp | 0.6 | $3.9M | 795k | 4.89 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $3.8M | 68k | 56.61 | |
| Tandem Diabetes Care | 0.6 | $3.7M | 277k | 13.42 | |
| Covance | 0.6 | $3.6M | 46k | 78.70 | |
| Zs Pharma | 0.6 | $3.6M | 92k | 39.23 | |
| FEI Company | 0.6 | $3.5M | 47k | 75.43 | |
| Intercept Pharmaceuticals In | 0.6 | $3.6M | 15k | 236.69 | |
| Epizyme | 0.6 | $3.6M | 131k | 27.11 | |
| Theravance Biopharma (TBPH) | 0.6 | $3.6M | 156k | 23.05 | |
| Cyberonics | 0.5 | $3.4M | 67k | 51.16 | |
| WuXi PharmaTech | 0.5 | $3.4M | 97k | 35.02 | |
| Medicines Company | 0.5 | $3.3M | 148k | 22.32 | |
| Theravance | 0.5 | $3.2M | 190k | 17.09 | |
| Cubist Pharmaceuticals | 0.5 | $3.1M | 47k | 66.34 | |
| Relypsa | 0.5 | $3.1M | 145k | 21.09 | |
| Jazz Pharmaceuticals (JAZZ) | 0.5 | $2.9M | 18k | 160.55 | |
| Infinity Pharmaceuticals (INFIQ) | 0.4 | $2.8M | 210k | 13.42 | |
| Kindred Biosciences | 0.4 | $2.5M | 275k | 9.25 | |
| Roka Bioscience | 0.4 | $2.5M | 250k | 10.05 | |
| Novavax | 0.4 | $2.4M | 575k | 4.17 | |
| Versartis | 0.4 | $2.4M | 124k | 18.99 | |
| Pfenex | 0.4 | $2.4M | 325k | 7.36 | |
| Kite Pharma | 0.4 | $2.4M | 83k | 28.51 | |
| Aerie Pharmaceuticals | 0.3 | $2.1M | 99k | 20.69 | |
| Cymabay Therapeutics | 0.3 | $2.1M | 300k | 6.84 | |
| Arrowhead Research | 0.3 | $1.7M | 115k | 14.77 | |
| Receptos | 0.2 | $1.4M | 23k | 62.09 | |
| EnteroMedics | 0.2 | $1.4M | 1.1M | 1.23 | |
| Five Prime Therapeutics | 0.2 | $1.3M | 115k | 11.73 | |
| XenoPort | 0.1 | $786k | 146k | 5.38 | |
| Heron Therapeutics (HRTX) | 0.1 | $583k | 70k | 8.33 | |
| Cerulean Pharma | 0.1 | $361k | 86k | 4.22 | |
| Avalanche Biotechnologies In | 0.0 | $246k | 7.2k | 34.18 |
